GENE ONLINE|News &
Opinion
Blog

Eye Disease
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
Adverum Advances Wet AMD Gene Therapy After Cutting Jobs
2022-07-18
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Birmingham University Spinout Looking to Tackle Ocular Surface Disorders
2022-04-26
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Backed by RTW, LENZ Therapeutics Inks $110 Vision Loss Pact with China’s JIXING
2022-04-14
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
Roche’s Injectable Eye Medicine Lessens Treatment Burden in Two Diseases
2021-02-19
November 12, 1946: English Geneticist Veronica Van Heyningen was Born
2017-11-12
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top